Table 1.
Characteristics of metastatic patients according to cancer site and stratified by presence/absence of clinical nutrition.
| Metastatic Patients with CN (N = 4814) | Metastatic Patients without CN (N = 48,228) | |||||||
|---|---|---|---|---|---|---|---|---|
| N (%) 1 | Age Mean (SD) | Men N (%) 2 | mCCI 3 Mean (SD) | N (%) 1 | Age Mean (SD) | Men N (%) 4 | mCCI 3 Mean (SD) | |
| All Clusters (N = 53,042) | 4814 (9.1%) | 67.2 (12.4) | 2925 (60.8%) | 1.0 (1.0) | 48,228 (90.9%) | 70.1 (12.2) | 30,259 (62.7%) | 1.0 (1.0) |
| Head and Neck (N = 2141) | 271 (12.7%) | 62.2 (12.0) | 199 (73.4%) | 0.8 (1.0) | 1870 (87.3%) | 65.3 (12.7) | 1387 (74.2%) | 0.9 (0.9) |
| Gastrointestinal (N = 23,667) | 2937 (12.4%) | 67.6 (12.5) | 1776 (60.5%) | 1.0 (1.0) | 20,730 (87.6%) | 70.8 (12.0) | 11,685 (57.2%) | 0.9 (1.0) |
| Respiratory (N = 14,475) | 814 (5.6%) | 67.2 (10.8) | 615 (75.6%) | 1.3 (1.1) | 13,661 (94.4%) | 69.7 (11.0) | 10,063 (73.7%) | 1.2 (1.0) |
| Genitourinary (N = 10,983) | 702 (6.4%) | 67.6 (13.2) | 287 (40.9%) | 1.0 (1.0) | 10,281 (93.6%) | 70.4 (13.2) | 5997 (58.3%) | 1.0 (0.9) |
| Hematology (N = 1776) | 90 (5.1%) | 67.5 (17.7) | 48 (53.3%) | 1.2 (1.2) | 1686 (94.9%) | 68.5 (14.4) | 947 (56.2%) | 1.0 (1.0) |
1 (First row) Proportions calculated over the total number of metastatic patients. (Following rows) Proportions calculated over the total number of metastatic patients with the corresponding cancer type. 2 (First row) Proportions calculated over the total number of metastatic patients who received clinical nutrition. (Following rows) Proportions calculated over the total number of metastatic patients with the corresponding cancer type who received clinical nutrition. 3 mCCI. Modified Charlson Comorbidity Index, not accounting for cancer. 4 (First row) Proportions calculated over the total number of metastatic patients who did not receive clinical nutrition. (Following rows) Proportions calculated over the total number of metastatic patients with the corresponding cancer type who did not receive clinical nutrition.